Similarly, AHNAK2, ARL4C, ASAP2 were all highly expressed in pancreatic cancers, correlated with KRAS G12D mutation and could predict survival in pancreatic cancers (Figure S3). This evidence concerns the gene ASAP2 and pancreatic neoplasm.